Holostem Terapie Avanzate has a highly experienced management team, with a sound know-how derived from a long tenure both in business administration and in academic research, successfully applied since many years in translational medicine.
MANAGEMENT
Andrea Chiesi
Chairman of the board of directors
Antonio Irione
CEO
Michele De Luca
Scientific Director
Graziella Pellegrini
R&D Director
Our Company
Holostem Terapie Avanzate is a university spin-off founded in 2008 through the profitable union among Michele De Luca and Graziella Pellegrini, the University of Modena and Reggio Emilia and Chiesi Farmaceutici S.p.A.
read moreScientific Background
Michele De Luca and Graziella Pellegrini are internationally recognized as leading scientists in the field of epithelial stem cell biology aimed at clinical application and played a pivotal role in epithelial stem cell-mediated cell therapy and gene therapy.
Publications
Our scientist are author of over 150 peer-reviewed publications in major international journals.